Navigating the regulatory maze

Cell and gene therapies raise specific challenges to securing regulatory approvals. This session will look in detail at those challenges and provide insight into effective regulatory strategies. We will also look at how regulatory systems need to adapt to keep pace with technological advancements such that ground-breaking and effective treatments are adopted quickly.


JAMES FRY | Partner and Head of Life Sciences | Mills & Reeve


AHMED BOUZIDI | Vice-President Biotech | ProductLife Group
AGATHE GUILLOT | Head of Regulatory Affairs | Cell and Gene Therapy Catapult
MARIAN REVIRIEGO | Executive Regulatory Consultant & Co-Founder | Alladvice
LEE CONEY | Head of Non-Clinical Safety | Cell and Gene Therapy Catapult
ELIZABETH FAIRLEY | Chief Operating Officer | Talking Medicines